Viewing Study NCT04261933


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-27 @ 5:22 PM
Study NCT ID: NCT04261933
Status: COMPLETED
Last Update Posted: 2023-03-28
First Post: 2020-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
Sponsor: Novo Nordisk A/S
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-02-13
Start Date Type: ACTUAL
Primary Completion Date: 2021-05-25
Primary Completion Date Type: ACTUAL
Completion Date: 2021-05-25
Completion Date Type: ACTUAL
First Submit Date: 2020-02-06
First Submit QC Date: None
Study First Post Date: 2020-02-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-24
Last Update Post Date: 2023-03-28
Last Update Post Date Type: ACTUAL